Imbruvica Interactions
There are 506 drugs known to interact with Imbruvica (ibrutinib), along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 198 are major, 302 are moderate, and 6 are minor.
- View all 506 medications that may interact with Imbruvica
- View Imbruvica alcohol/food interactions (3)
- View Imbruvica disease interactions (8)
Most frequently checked interactions
View interaction reports for Imbruvica (ibrutinib) and the medicines listed below.
- acyclovir
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- Eliquis (apixaban)
- famotidine
- finasteride
- furosemide
- gabapentin
- hydrochlorothiazide
- levofloxacin
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- ondansetron
- pantoprazole
- prednisone
- simvastatin
- tamsulosin
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Imbruvica alcohol/food interactions
There are 3 alcohol/food interactions with Imbruvica (ibrutinib).
Imbruvica disease interactions
There are 8 disease interactions with Imbruvica (ibrutinib) which include:
- arrhythmias
- bleeding
- cytopenia
- hepatic impairment
- hypertension
- infections
- renal impairment
- tumor lysis syndrome
Report options
More about Imbruvica (ibrutinib)
- Imbruvica consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (69)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Zanubrutinib
Zanubrutinib is a targeted treatment that may be used to treat adults with chronic lymphocytic ...
Acalabrutinib
Acalabrutinib (Calquence) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
